dilevalol has been researched along with propranolol in 3 studies
| Studies (dilevalol) | Trials (dilevalol) | Recent Studies (post-2010) (dilevalol) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 33,310 | 3,406 | 3,218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clifton, JE; Collins, I; Hallett, P; Hartley, D; Lunts, LH; Wicks, PD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
3 other study(ies) available for dilevalol and propranolol
| Article | Year |
|---|---|
Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Chemical Phenomena; Chemistry; Dogs; Ethanolamines; Labetalol; Muscle, Smooth, Vascular; Phentolamine; Propranolol; Salicylamides; Stereoisomerism; Structure-Activity Relationship | 1982 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |